The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
Open accessAbstract
Click to hear Dr Baglin's perspective on the role of the laboratory in treatment with new oral anticoagulants SUMMARY: One of the key benefits of the direct oral anticoagulants (DOACs) is that they do not require routine laboratory monitoring. Nevertheless, assessment of DOAC exposure and anticoagulant effects may become useful in various clinical scenarios. The five approved DOACs (apixaban, betrixaban, dabigatran etexilate, edoxaban and rivaroxaban) have different characteristics impacting assay selection and the interpretation of results. This article provides an updated overview on (i) which test to use (and their advantages and limitations), (ii) when to assay DOAC levels, (iii) how to interpret the results relating to bleeding risk, emergency situations and perioperative management, and (iv) what is the impact of DOACs on routine and specialized coagulation assays. Assays for anti-Xa or anti-IIa activity are the preferred methods when quantitative information is useful, although the situations in which to test for DOAC levels are still debated. Different reagent sensitivities and variabilities in laboratory calibrations impact assay results. International calibration standards for all specific tests for each DOAC are needed to reduce the inter-laboratory variability and allow inter-study comparisons. The impact of the DOACs on hemostasis testing may cause false-positive or false-negative results; however, these can be minimized by using specific assays and collecting blood samples at trough concentrations. Finally, prospective clinical trials are needed to validate the safety and efficacy of proposed laboratory thresholds in relation to clinical decisions. We offer recommendations on the tests to use for measuring DOACs and practical guidance on laboratory testing to help patient management and avoid diagnostic errors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ageno, W., Gallus, A. S., Wittkowsky, A., Crowther, M., Hylek, E. M., & Palareti, G. (2012) · Chest · doi:10.1378/chest.11-2292 · Cited by 1,503
Self-citationHeidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.-C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2015) · Europace · doi:10.1093/europace/euv309 · Cited by 1,113
Self-citationReilly, P. A., Lehr, T., Haertter, S., Connolly, S. J., Yusuf, S., Eikelboom, J. W., Ezekowitz, M. D., Nehmiz, G., Wang, S., & Wallentin, L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.104 · Cited by 834
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Mueck, W., Stampfuss, J., Kubitza, D., & Becka, M. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0100-7 · Cited by 612
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
Cuker, A., Siegal, D. M., Crowther, M. A., & Garcia, D. A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.065 · Cited by 449
Ruff, C. T., Giugliano, R. P., Braunwald, E., Morrow, D. A., Murphy, S. A., Kuder, J. F., Deenadayalu, N., Jarolim, P., Betcher, J., Shi, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61943-7 · Cited by 405
Levy, J. H., Ageno, W., Chan, N. C., Crowther, M., Verhamme, P., & Weitz, J. I. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13227 · Cited by 375
Self-citationNarouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., De Andres, J., Deer, T. R., Rauck, R., & Huntoon, M. A. (2015) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 362
Connolly, S., Patel, I., Salazar, D., Rohatagi, S., Mendell, J., Kastrissios, H., Jin, J., Kunitada, S., & Weitz, J. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0066 · Cited by 341
Pernod, G., Albaladejo, P., Godier, A., Samama, C. M., Susen, S., Gruel, Y., Blais, N., Fontana, P., Cohen, A., Llau, J. V., et al. (2013) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2013.04.009 · Cited by 309
Self-citationHeidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.-C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw058 · Cited by 269
Self-citationDouxfils, J., Mullier, F., Loosen, C., Chatelain, C., Chatelain, B., & Dogné, J.-M. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.004 · Cited by 248
Self-citationSteiner, T., Böhm, M., Dichgans, M., Diener, H.-C., Ell, C., Endres, M., Epple, C., Grond, M., Laufs, U., Nickenig, G., et al. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0560-7 · Cited by 183
Godiér, A., Dincq, A.-S., Martin, A., Radu, A., Leblanc, I., Antona, M., Vasse, M., Golmard, J., Mullier, F., & Gouin‐Thibault, I. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx403 · Cited by 152
Self-citationEikelboom, J. W., Quinlan, D. J., Hirsh, J., Connolly, S. J., & Weitz, J. I. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0364 · Cited by 145
Gosselin, R. C., Grant, R. P., & Adcock, D. M. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12528 · Cited by 121
Lippi, G., & Favaloro, E. J. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0767 · Cited by 117
Bonar, R. A., Favaloro, E. J., Mohammed, S., Ahuja, M., Pasalic, L., Sioufi, J., & MARSDEN, K. A. (2015) · Pathology · doi:10.1016/j.pathol.2015.11.025 · Cited by 111
Lippi, G., & Favaloro, E. J. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1546827 · Cited by 109
Testa, S., Legnani, C., Tripodi, A., Paoletti, O., Pengo, V., Abbate, R., Bassi, L., Carraro, P., Cini, M., Paniccia, R., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13486 · Cited by 88
Laboratory Assessment of Direct Oral Anticoagulants
Gosselin, R. C., & Douxfils, J. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1597296 · Cited by 87
Self-citationEdoxaban: Impact on routine and specific coagulation assays
Châtelain, B., Chatelain, C., Douxfils, J., Dogné, J., & Mullier, F. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-05-0415 · Cited by 80
Self-citationSeiffge, D. J., Traenka, C., Polymeris, A. A., Thilemann, S., Wagner, B., Hert, L., Müller, M. D., Gensicke, H., Peters, N., Nickel, C. H., et al. (2017) · Journal of Stroke · doi:10.5853/jos.2017.00395 · Cited by 79
Bonar, R. A., Favaloro, E. J., Mohammed, S., Pasalic, L., Sioufi, J., & MARSDEN, K. A. (2015) · Pathology · doi:10.1097/pat.0000000000000252 · Cited by 77
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures
Tripodi, A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13344 · Cited by 76
Urgent Need to Measure Effects of Direct Oral Anticoagulants
Weitz, J. I., & Eikelboom, J. W. (2016) · Circulation · doi:10.1161/circulationaha.116.022307 · Cited by 63
Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care
Gulilat, M., TANG, A. S. L., Gryn, S. E., Leong‐Sit, P., Skanes, A. C., Alfonsi, J., Dresser, G. K., Henderson, S. L., Rose, R. V., Lizotte, D. J., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.04.008 · Cited by 62
Direct oral anticoagulant drug level testing in clinical practice: A single institution experience
Martin, K. A., & Moll, S. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.04.019 · Cited by 61
The laboratory's 2015 perspective on direct oral anticoagulant testing
Gosselin, R. C., & Adcock, D. M. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13266 · Cited by 55
Lupus-anticoagulant testing at NOAC trough levels
Ratzinger, F., Lang, M., Belik, S., Jilma‐Stohlawetz, P., Schmetterer, K. G., Haslacher, H., Perkmann, T., & Quehenberger, P. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-02-0081 · Cited by 54
Godiér, A., Martin, A., Leblanc, I., Mazoyer, E., Horellou, M., Ibrahim, F., Flaujac, C., Golmard, J., Rosencher, N., & Gouin‐Thibault, I. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.08.006 · Cited by 51
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism
Wells, P. S., Segers, A. E. M., Ageno, W., Brekelmans, M. P. A., Cohen, A. T., Meyer, G., GROSSO, M. A., Raskob, G., Weitz, J. I., Zhang, G., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0244 · Cited by 45
Self-citationFeasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke
Seiffge, D. J., Traenka, C., Polymeris, A. A., Hert, L., Fisch, U., Peters, N., Marchis, G. M. D., Guzman, R. G., Nickel, C. H., Lyrer, P., et al. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1431-7 · Cited by 45
Spyropoulos, A. C., Al-Badri, A., Sherwood, M. W., & Douketis, J. D. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13505 · Cited by 41
Wright, C. M., Brown, R., & Cuker, A. C. (2017) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12654 · Cited by 41
Impact of rivaroxaban on point-of-care assays
Fontana, P., Alberio, L., Angelillo‐Scherrer, A., Asmis, L. M., Korte, W. C., Méndez, A., Schmid, P., Stricker, H. J., Studt, J., Tsakiris, D. A., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.03.019 · Cited by 39
Lessire, S., Douxfils, J., Pochet, L., Dincq, A.-S., Larock, A., Gourdin, M. J., Dogné, J., Châtelain, B., & Mullier, F. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616675968 · Cited by 35
Self-citationDose tailoring of dabigatran etexilate: obvious or excessive?
Douxfils, J., Mullier, F., & Dogné, J.-M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1049995 · Cited by 26
Self-citationDouxfils, J., Pochet, L., Lessire, S., Vancraeynest, C., Dogné, J., & Mullier, F. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.01.029 · Cited by 25
Self-citationPeriprocedural Management of Direct Oral Anticoagulants
Douketis, J. D., Syed, S., & Schulman, S. (2016) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000360 · Cited by 22
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply
Tripodi, A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13513 · Cited by 22
Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)
Douxfils, J., Adcock, D. M., & Gosselin, R. C. (2017) · Hämostaseologie · doi:10.5482/hamo-17-01-0002 · Cited by 14
Self-citationBrunetti, L., Sanchez-Catanese, B., Kagan, L., Wen, X., Liu, M., Buckley, B., Luyendyk, J. P., & Aleksunes, L. M. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0084-2 · Cited by 13
Benzon, H. T., Lindholm, P. F., & Huntoon, M. A. (2016) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000373 · Cited by 9
Byron, M., Zochert, S., Hellwig, T. R., Gavozdea-Barna, M., & Gulseth, M. P. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160168 · Cited by 9
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Self-citationSteffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Self-citationRossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Spahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
Self-citationSteffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Metadata
- Authors
- Douxfils, J., Ageno, W., Samama, C. ‐., Lessire, S., ten Cate, H., Verhamme, P., Dogné, J. ‐., & Mullier, F.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 16
- Issue
- 2
- Pages
- 209-219
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W2769760280
- Cited by
- 382
- References
- 45
- FWCI
- 24.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.